Total Payments
$4,790
2024 Payments
$110.94
Companies
33
Transactions
227
Medicare Patients
2,635
Medicare Billing
$510,729
Payment Breakdown by Category
Food & Beverage$4,328 (90.4%)
Education$461.47 (9.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,328 | 219 | 90.4% |
| Education | $461.47 | 8 | 9.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $851.01 | 31 | $0 (2018) |
| PFIZER INC. | $493.14 | 22 | $0 (2024) |
| Genentech USA, Inc. | $471.66 | 23 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $378.48 | 27 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $268.72 | 23 | $0 (2018) |
| Lilly USA, LLC | $217.13 | 12 | $0 (2019) |
| TESARO, Inc. | $209.39 | 5 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $203.29 | 13 | $0 (2018) |
| Millennium Pharmaceuticals, Inc. | $202.47 | 5 | $0 (2017) |
| Incyte Corporation | $181.85 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $110.94 | 1 | PFIZER INC. ($110.94) |
| 2023 | $78.04 | 1 | PFIZER INC. ($78.04) |
| 2022 | $118.87 | 2 | PFIZER INC. ($118.87) |
| 2021 | $15.73 | 1 | Dova Pharmaceuticals ($15.73) |
| 2019 | $144.20 | 2 | Janssen Biotech, Inc. ($122.62) |
| 2018 | $2,094 | 112 | Amgen Inc. ($519.00) |
| 2017 | $2,228 | 108 | Amgen Inc. ($332.01) |
All Payment Transactions
227 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/25/2024 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $110.94 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2023 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $78.04 | General |
| Category: ONCOLOGY | ||||||
| 10/26/2022 | PFIZER INC. | IBRANCE (Drug), TALZENNA, PAXLOVID | Food and Beverage | In-kind items and services | $112.02 | General |
| Category: ONCOLOGY | ||||||
| 08/17/2022 | PFIZER INC. | BOSULIF (Drug) | Education | In-kind items and services | $6.85 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 09/16/2021 | Dova Pharmaceuticals | Doptelet (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Hematology/Oncology | ||||||
| 09/19/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $122.62 | General |
| Category: Oncology | ||||||
| 01/04/2019 | Lilly USA, LLC | ERBITUX (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Oncology | ||||||
| 12/13/2018 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: BioOncology | ||||||
| 12/12/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Oncology | ||||||
| 12/06/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2018 | Lilly USA, LLC | CYRAMZA (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Oncology | ||||||
| 11/29/2018 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Oncology | ||||||
| 11/21/2018 | PFIZER INC. | BOSULIF (Drug) | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/19/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Endocrinology | ||||||
| 11/15/2018 | MEDIVATION FIELD SOLUTIONS LLC | XTANDI (Drug) | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $10.13 | General |
| Category: Oncology | ||||||
| 11/08/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $1.68 | General |
| Category: Oncology | ||||||
| 11/07/2018 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2018 | Amgen Inc. | Neulasta (Biological), Vectibix | Food and Beverage | In-kind items and services | $32.75 | General |
| Category: Oncology | ||||||
| 10/25/2018 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: BioOncology | ||||||
| 10/24/2018 | Lilly USA, LLC | CYRAMZA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Oncology | ||||||
| 10/18/2018 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $12.23 | General |
| Category: Oncology | ||||||
| 10/17/2018 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Oncology | ||||||
| 10/12/2018 | Genentech USA, Inc. | Herceptin (Biological), Perjeta, Kadcyla | Education | In-kind items and services | $88.11 | General |
| Category: BioOncology | ||||||
| 10/12/2018 | Genentech USA, Inc. | Herceptin (Biological), Perjeta, Kadcyla | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 526 | 1,260 | $410,050 | $94,299 |
| 2022 | 11 | 628 | 1,444 | $463,240 | $106,575 |
| 2021 | 11 | 673 | 1,668 | $518,365 | $125,586 |
| 2020 | 11 | 808 | 2,415 | $641,585 | $184,269 |
Total Patients
2,635
Total Services
6,787
Medicare Billing
$510,729
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 334 | $133,600 | $25,515 | 19.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 66 | 292 | $49,640 | $19,552 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 139 | 358 | $98,450 | $18,344 | 18.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 59 | 64 | $30,080 | $9,415 | 31.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 73 | $39,055 | $8,665 | 22.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 39 | $9,750 | $3,936 | 40.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 27 | 27 | $20,250 | $3,551 | 17.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 18 | 29 | $11,600 | $2,226 | 19.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $10,200 | $1,694 | 16.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 14 | 27 | $7,425 | $1,401 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 383 | $153,200 | $29,466 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 159 | 401 | $110,275 | $20,335 | 18.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 88 | 318 | $54,060 | $19,410 | 35.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 79 | 88 | $41,360 | $14,885 | 36.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 58 | $31,030 | $6,980 | 22.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 33 | 33 | $24,750 | $4,790 | 19.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 27 | 45 | $11,250 | $3,967 | 35.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 32 | 49 | $13,475 | $2,285 | 17.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 16 | 23 | $9,200 | $1,797 | 19.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $11,400 | $1,768 | 15.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 27 | $3,240 | $891.29 | 27.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 132 | 407 | $162,800 | $32,448 | 19.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 97 | 429 | $72,930 | $26,551 | 36.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 145 | 359 | $98,725 | $19,600 | 19.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 79 | 89 | $41,830 | $15,304 | 36.6% |
About Dr. Henry Wang, MD
Dr. Henry Wang, MD is a Hematology & Oncology healthcare provider based in Arcadia, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245255587.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Henry Wang, MD has received a total of $4,790 in payments from pharmaceutical and medical device companies, with $110.94 received in 2024. These payments were reported across 227 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($4,328).
As a Medicare-enrolled provider, Wang has provided services to 2,635 Medicare beneficiaries, totaling 6,787 services with total Medicare billing of $510,729. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Arcadia, CA
- Active Since 07/13/2006
- Last Updated 11/27/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1245255587
Products in Payments
- Nplate (Biological) $339.27
- IBRANCE (Drug) $308.17
- Kyprolis (Biological) $175.68
- TASIGNA (Drug) $175.05
- OPDIVO (Biological) $167.96
- KEYTRUDA (Biological) $164.26
- VARUBI (Drug) $162.24
- Cabometyx (Drug) $160.96
- CYRAMZA (Drug) $147.01
- Neulasta (Biological) $135.76
- TECENTRIQ (Biological) $134.65
- Herceptin (Biological) $127.43
- Erleada (Drug) $122.62
- NINLARO (Drug) $103.27
- VELCADE (Drug) $98.20
- XTANDI (Drug) $96.14
- SUTENT (Drug) $87.04
- Xofigo (Drug) $86.46
- JAKAFI (Drug) $81.90
- BOSULIF (Drug) $72.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Arcadia
Dr. Monty Polonsky, M.d, M.D
Hematology & Oncology — Payments: $22,743
Hematology & Oncology $22,743
Ms. Jeany Cheng, N.p, N.P
Hematology & Oncology — Payments: $7,348
Hematology & Oncology $7,348
Dr. Richard Shapiro, M.d, M.D
Hematology & Oncology — Payments: $801.02
Hematology & Oncology $801.02
Dr. Benjamin Stafford, M.d, M.D
Hematology & Oncology — Payments: $18.80
Hematology & Oncology $18.80